ログアウト
ライト
ダーク
戻る
-
マーケット
-
注目機能
-
ニュース
-
Moo
-
学ぶ
-
もっと見る
- 日本語
- ダーク
- ライト
クレセント・エナジーに関するコメント
Warren Buffett vs Michael Burry
コラムToday's Pre-Market Stock Movers: NIO, PATH, COUP, RKLB and More
In reaction to earnings/guidance:
• $Coupa Software(COUP.US)$ +12% (also authorizes new $100mln share repurchase program),$REVグループ(REVG.US)$ -5%,$G-IIIアパレル・グループ(GIII.US)$ + 2.1%,$ギットラブ(GTLB.US)$ +1.2%
Other news:
• $タッパーウェア・ブランズ(TUP.US)$ +6.7% (recovers a bit after falling -33% during regular session)
• $Avaya Holdings(AVYA.US)$ +6.6% (authorizes workforce reduction plan)
• $バセット・ファニチャー・インダストリーズ(BSET.US)$ +5% (acqu...
コラムToday's pre-market stock movers: DWAC, GS, MU, EDU and more
• $デイ・ワン・バイオファーマシューティカルズ(DAWN.US)$ +67.7% (Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma)
• $Gracell Biotechnologies(GRCL.US)$ +12.1% (Presents Updated Clinical Data for BCMA/CD19 Dual-targeting FasTCAR GC012F in RRMM at EHA2022 Congress, Highlighting 100% MRD Negativity Rate in All Treated Patients)
• $iPath Series B S&P 500 VIX Short-Term Futures ETN(VXX.US)$ +6...
コラムToday's pre-market stock movers: NIO, XPEV, AAPL, NVDA and more
• $SailPoint Technologies(SAIL.US)$ +30% (confirms agreement to be acquired by Thoma Bravo for $6.9 bln; stockholders to receive $65.25 per share in cash)
• $ベル(VERU.US)$ +28.9% (Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy)
• $アフィメド(AFMD.US)$ +12.9% (Presents Upda...
コラムTop upgrades and downgrades on 4/8
• $アフヤ(AFYA.US)$: Credit Suisse Upgrades to Outperform from Neutral - PT $19 (from $18)
• $アップフォリオ(APPF.US)$: KeyBanc Upgrades to Overweight from Sector Weight - PT $143
• $シー･エッチ・ロビンソン・ワールドワイド(CHRW.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $117 (from $91)
• $クーパン(CPNG.US)$: Goldman Sachs Upgrades to Conviction Buy from Buy - PT $37
• $ガトス・シルバー(GATO.US)$: RBC Capital Upgrades to Sector Perform from Underperform - PT $4
• $ITT(ITT.US)$: UBS Upgr...
まだコメントはありません